We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Management Appointments

17 Dec 2008 17:52

RNS Number : 3515K
Phorm Inc
17 December 2008
 



Phorm, Inc. ("Phorm" or the "Company")

Management Appointments

Phorm (AIM: PHRM and PHRX), the innovative digital advertising business, today announces three key executive appointments. These changes will strengthen the Company's leadership team through the next important phase of its development. The UK based executive management will ensure the deliverability of the Group's core strategic objective of deploying Phorm's technology both in the UK and internationally whilst managing cash resources in a prudent fashion.

Nan Richards is appointed Deputy Chief Executive Officer based in London. Nan's primary responsibility will be to work with Chief Executive, Kent Ertugrul, to deliver Phorm's operational goals. Nan Richards was previously President of Turner Broadcasting System Europe, a division of Time Warner. She brings with her a wealth of operational and strategic experience having spent 20 years working on Turner's leading broadcast brands including CNN, Cartoon Network and TCM. 

Hugo Drayton, UK Chief Executive, will leave the Company by mutual agreement at the end of 2008, though he will remain an advisor to the Company. Hugo Drayton commented: "My time with Phorm has been exciting and rewarding. Whilst I am looking forward to exploring new challenges in the fast-evolving media world, I am delighted that I will continue to contribute to the dynamic, industry-changing future of Phorm. I am very happy with the progress we've made in recent months with our ISP partners and our advertising and publishing clients. In 2009 we expect that Phorm's Open Internet Exchange (OIX) will be commercially deployed and I am very proud that the team we have established is now fully prepared to deliver on the Company's enormous potential."

Andrew Croxson is appointed Global CFO on an interim basis. Andrew joins from the Technology, Media and Telecommunications (TMT) specialists Ingenious Consulting. Prior to that, Andrew was a partner at Spectrum Strategy Consultants. He is an ACA qualified chartered accountant and has a Masters Degree from both Oxford and Cambridge Universities. As well as Andrew's significant financial knowledge, he also brings deep experience of advising brand leading media and technology companies and strategic insights into building and scaling global operations. He will replace Lynne Millar who has resigned as UK CFO.

Nick Barnett, currently Phorm's UK Commercial Director, is promoted to the newly created role of UK Managing Director based in London. Nick will be responsible for the UK business working with ISPs on the trial and deployment of Phorm's technology as well as overseeing our commercial relationships with advertisers, publishers and ad networks. Before joining Phorm, Nick was VP of Corporate Strategy and Development at Telefonica O2 Europe and prior to that he was a senior manager with McKinsey & Company specialising in the TMT sector.

Kent Ertugrul, Chief Executive of Phorm, commented: "I'd like to welcome Nan, Andrew, and Nick to their new roles. Their appointments are central to the delivery of our strategic objectives through the next important phase of our development.

 

"I thank both Hugo and Lynne for their significant contributions and wish them well in their future endeavours. They have helped lay the foundations for a successful commercial launch in the UK and beyond. I am delighted that Hugo will build on his previous achievements with Phorm as an advisor.

"We have made significant progress in the development of partnerships and the testing of our technology. I am also pleased that we have completed the trial with BT and look forward to moving to the next stage of development.

"I am confident that we have the right talent at both the Board and executive level to deliver on the huge potential of our technology and the business opportunity that lies ahead. I believe that we are now uniquely placed to lead the introduction of privacy-assured behavioural advertising across the whole of the Internet."

For Phorm Enquiries:

Kent Ertugrul (Chief Executive)

+44 20 7638 9571

Citigate Dewe Rogerson

+44 20 7638 9571

Simon Rigby

Justin Griffiths

Canaccord Adams Limited

+44 20 7050 6500

(Nominated Adviser)

Mark Williams

Andrew Chubb

About Phorm:

Phorm is an innovative technology company specialising in delivering behaviourally and contextually targeted advertising while preserving users' personal privacy and security. Phorm's partners include leading Internet Service Providers (ISPs), Publishers, Ad Networks and Advertisers.

Phorm is a Delaware, US incorporated company, with offices in New York and London. The Company was admitted to the AIM market of the London Stock Exchange in 2004 and has over 100 employees.

For more information, please visit: www.phorm.com http://www.phorm.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAFKOKQOBDDOBD
Date   Source Headline
14th Apr 201610:00 amRNSUpdate and Resignation of Nominated Adviser
16th Mar 201612:37 pmRNSIssue of US$500,000 of Convertible Loan Notes
16th Mar 20167:00 amRNSIssue of US$500,000 of Convertible Loan Notes
25th Feb 20168:02 amRNSFunding Update and Statement re Suspension
25th Feb 20167:55 amRNSSuspension - Phorm Corporation Limited
4th Feb 20166:05 pmRNSFunding Update
1st Feb 20163:49 pmRNSSubscription Update, New Subscription & Loan
21st Jan 20167:00 amRNSPhorm Awarded TRUSTe Certified Privacy Seal
18th Jan 20167:00 amRNSSubscription & Operational Update
5th Jan 20162:00 pmRNSTR-1: Notification of major interest in shares
23rd Dec 20151:00 pmRNSRevised Non-Executive Director Compensation
22nd Dec 20157:00 amRNSDirectorate Change
7th Dec 20157:00 amRNSRepricing of Options
3rd Dec 201511:00 amRNSPhorm Enables Hover Rate with Insomnis Media
1st Dec 20157:00 amRNSNew Share Option Plan and Grant of Options
18th Nov 20157:00 amRNSTR-1: Notifications of Major Interests in Shares
28th Oct 20157:00 amRNSPartnering Agreement with INSOMNIS Media Limited
20th Oct 20157:00 amRNSAgreement with Causemo, Inc.
13th Oct 20157:00 amRNSPhorm Hires Chief Revenue Officer
9th Oct 20157:00 amRNSAgreement with Boston Globe Media Group
30th Sep 20151:33 pmRNSInterim Results
28th Aug 20152:38 pmRNSResult of AGM
10th Aug 20157:00 amRNSNotice of Annual General Meeting
7th Aug 20157:48 amRNSEquity fundraising of approximately £3.2 million
29th Jul 20157:02 amRNSUpdate re Board Changes
28th Jul 20157:00 amRNSLoan Agreement & Convertible Loan Note Extension
15th Jul 201511:21 amRNSBoard and Management Changes
3rd Jul 20157:00 amRNSOperational Update
2nd Jul 20157:16 amRNSDirectorate Change
30th Jun 20157:00 amRNSAnnual Financial Report
8th May 20154:00 pmRNSTR-1: Notification of major interest in shares
22nd Apr 20157:00 amRNSEquity Fundraising of £6.0 million Gross
21st Apr 20154:22 pmRNSOperational Update
16th Mar 20153:45 pmRNSDirectorate Change
25th Feb 20157:02 amRNSBoard Changes
19th Jan 20157:00 amRNSEquity fundraising of approximately £6.25 million
16th Jan 20157:21 amRNSOperational Update
8th Dec 20147:00 amRNSEquity Fundraising
28th Oct 20147:00 amRNSTR-1: Notification of major interest in shares
8th Oct 20147:00 amRNSEquity fundraising of £4.47 million
6th Oct 20147:00 amRNSOperational Update
22nd Aug 20147:05 amRNSSubscription To Raise £2.4 million
22nd Aug 20147:00 amRNSInterim Results
24th Jul 20142:31 pmRNSResult of Annual General Meeting
27th Jun 20147:30 amRNSGlobal Operations Update
27th Jun 20147:05 amRNSNotice of Annual General Meeting and Board Changes
27th Jun 20147:00 amRNSFinal Results for the Year Ended 31 December 2013
23rd Apr 20144:25 pmRNSTR-1: Notification of major interest in shares
14th Apr 201412:40 pmRNSResult of EGM
27th Mar 20147:00 amRNSProposed £10m Placing & Notice of EGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.